NDT Advance Access originally published online on April 6, 2005
Nephrology Dialysis Transplantation 2005 20(7):1329-1335; doi:10.1093/ndt/gfh812
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes
1 Department of Nephrology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland and 2 John Walls Renal Unit, Leicester University Hospitals, Leicester, UK
Correspondence and offprint requests to: Dr Daniel Teta, MD, Department of Nephrology, Centre Hospitalier Universitaire Vaudois (CHUV), Bugnon 17, 1011 Lausanne, Switzerland. Email: Daniel.Teta{at}chuv.hospvd.ch
Background. A marked elevation of serum leptin is observed soon after the start of peritoneal dialysis (PD), suggesting that leptin production may be stimulated by this treatment. Glucose metabolism is the major factor regulating leptin. The current study was designed to test if glucose-based PD fluids might regulate leptin production in vitro.
Methods. 3T3-L1 adipocytes were exposed to a 50:50 mixture of dialysis solutions and medium M199 containing 10% serum for 
48 h. Leptin secretion in culture cell supernatants was measured by enzyme-linked immunosorbent assay and leptin mRNA content by northern blot analysis.
Results. The high glucose-based commercial dialysate PD4 produced a higher leptin secretion compared with an identical laboratory-manufactured dialysate (Lab-D), but with a physiological glucose concentration of 5 mM (P<0.05). Raising glucose concentration from 2.75 to 40 mM in Lab-D induced a dose-dependent increase in leptin secretion of 110±12% at 48 h (P<0.001) and leptin mRNA (P<0.05; glucose 2.75 vs 40 mM). Inhibition of UDP-N-acetylglucosamine biosynthesis, with 6-diazo-5-oxo-norleucine added to Lab-D, abolished most of the glucose-stimulated leptin release and downregulated leptin gene expression. Furthermore, glucose-free Lab-D supplemented with 1 mM glucosamine, an intermediate product in UDP-N-acetylglucosamine biosynthesis, increased leptin secretion by 28±11% over control (P<0.05), although without effect on leptin mRNA, after 48 h of culture.
Conclusions. These results suggest that the PD-induced hyperleptinaemia could, in part, be mediated by the effect of glucose-based dialysis fluids on leptin production by adipocytes via activation of the hexosamine biosynthetic pathway.
Keywords: adipocyte cultures; glucose; glucosamine; hexosamine pathway; leptin secretion; peritoneal dialysis fluids
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. B. McCormick and J. M. Bargman Noninfectious Complications of Peritoneal Dialysis: Implications for Patient and Technique Survival J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3023 - 3025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Teta, M. Maillard, A. Tedjani, J. Passlick-Deetjen, and M. Burnier The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes Nephrol. Dial. Transplant., March 1, 2007; 22(3): 862 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lynch, B. Gern, C. Lloyd, S. M. Hutson, R. Eicher, and T. C. Vary Leucine in food mediates some of the postprandial rise in plasma leptin concentrations Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E621 - E630. [Abstract] [Full Text] [PDF]
|
|